PetIQ, Inc. (PETQ)
USD 30.98
(-0.03%)
USD 30.98
(-0.03%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 252.74 Million USD | 20.55% |
| 2022 | 209.66 Million USD | 12.48% |
| 2021 | 186.39 Million USD | 37.88% |
| 2020 | 135.18 Million USD | 25.89% |
| 2019 | 107.38 Million USD | 28.93% |
| 2018 | 83.28 Million USD | 62.69% |
| 2017 | 51.19 Million USD | 57.29% |
| 2016 | 32.54 Million USD | -16.88% |
| 2015 | 39.15 Million USD | 79.64% |
| 2014 | 21.79 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 74.54 Million USD | 69.45% |
| 2024 Q2 | 88.28 Million USD | 18.43% |
| 2023 Q3 | 72.61 Million USD | -1.72% |
| 2023 Q4 | 43.99 Million USD | -39.42% |
| 2023 FY | 252.74 Million USD | 20.55% |
| 2023 Q2 | 73.87 Million USD | 18.66% |
| 2023 Q1 | 62.26 Million USD | 58.49% |
| 2022 Q3 | 50.77 Million USD | -18.08% |
| 2022 FY | 209.66 Million USD | 12.48% |
| 2022 Q1 | 57.63 Million USD | 56.22% |
| 2022 Q4 | 39.28 Million USD | -22.62% |
| 2022 Q2 | 61.97 Million USD | 7.53% |
| 2021 Q1 | 47.79 Million USD | 67.23% |
| 2021 Q2 | 59.62 Million USD | 24.75% |
| 2021 Q3 | 42.07 Million USD | -29.44% |
| 2021 Q4 | 36.89 Million USD | -12.31% |
| 2021 FY | 186.39 Million USD | 37.88% |
| 2020 Q3 | 32.26 Million USD | -23.51% |
| 2020 Q2 | 42.18 Million USD | 31.19% |
| 2020 Q1 | 32.15 Million USD | 57.14% |
| 2020 FY | 135.18 Million USD | 25.89% |
| 2020 Q4 | 28.58 Million USD | -11.42% |
| 2019 Q4 | 20.46 Million USD | -25.02% |
| 2019 FY | 107.38 Million USD | 28.93% |
| 2019 Q3 | 27.29 Million USD | -21.8% |
| 2019 Q2 | 34.9 Million USD | 41.13% |
| 2019 Q1 | 24.73 Million USD | 46.29% |
| 2018 FY | 83.28 Million USD | 62.69% |
| 2018 Q1 | 15.88 Million USD | 50.89% |
| 2018 Q2 | 26.31 Million USD | 65.7% |
| 2018 Q3 | 24.18 Million USD | -8.12% |
| 2018 Q4 | 16.9 Million USD | -30.09% |
| 2017 Q4 | 10.52 Million USD | -15.91% |
| 2017 Q1 | 12.2 Million USD | 59.39% |
| 2017 FY | 51.19 Million USD | 57.29% |
| 2017 Q2 | 15.95 Million USD | 30.75% |
| 2017 Q3 | 12.51 Million USD | -21.53% |
| 2016 Q1 | 9.77 Million USD | 0.0% |
| 2016 Q4 | 7.65 Million USD | 24.25% |
| 2016 Q3 | 6.16 Million USD | -31.26% |
| 2016 Q2 | 8.96 Million USD | -8.3% |
| 2016 FY | 32.54 Million USD | -16.88% |
| 2015 Q1 | 12.36 Million USD | 0.0% |
| 2015 FY | 39.15 Million USD | 79.64% |
| 2014 FY | 21.79 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | 22.513% |
| Embecta Corp. | 749.9 Million USD | 66.297% |
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | 17.217% |
| Dynavax Technologies Corporation | 182.11 Million USD | -38.779% |
| Esperion Therapeutics, Inc. | 73.06 Million USD | -245.902% |
| Pacira BioSciences, Inc. | 490.3 Million USD | 48.453% |
| PainReform Ltd. | -15 Thousand USD | 1685033.333% |
| Aquestive Therapeutics, Inc. | 29.75 Million USD | -749.489% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -2930.757% |
| SCYNEXIS, Inc. | 124.51 Million USD | -102.976% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | -45523.327% |
| Cosmos Health Inc. | 4.34 Million USD | -5710.691% |
| Journey Medical Corporation | 52.52 Million USD | -381.217% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -2930.757% |
| Safety Shot Inc | -74.45 Thousand USD | 339544.243% |
| Alpha Teknova, Inc. | 10.29 Million USD | -2354.74% |
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | 41.309% |
| Bright Green Corporation | -237.01 Thousand USD | 106734.151% |
| Procaps Group, S.A. | 239.56 Million USD | -5.498% |
| Theratechnologies Inc. | 62.12 Million USD | -306.799% |
| Harrow Health, Inc. | 90.55 Million USD | -179.107% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | -5226.449% |
| Biofrontera Inc. | 16.62 Million USD | -1420.058% |
| DURECT Corporation | 6.83 Million USD | -3599.898% |
| Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 51.743% |
| Cronos Group Inc. | 6.99 Million USD | -3515.273% |
| OptiNose, Inc. | 62.35 Million USD | -305.331% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 42.71% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | 83512.541% |
| RedHill Biopharma Ltd. | 3.05 Million USD | -8175.235% |
| Organogenesis Holdings Inc. | 309.79 Million USD | 18.416% |
| Guardion Health Sciences, Inc. | 5.39 Million USD | -4585.128% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | -654.766% |
| Radius Health, Inc. | 307.71 Million USD | 17.864% |
| Universe Pharmaceuticals INC | 10.07 Million USD | -2407.869% |
| ProPhase Labs, Inc. | 16.23 Million USD | -1456.377% |
| Phibro Animal Health Corporation | 312.48 Million USD | 19.12% |
| Procaps Group S.A. | 239.56 Million USD | -5.498% |
| Alvotech | -69.42 Million USD | 464.063% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -19311.674% |
| Viatris Inc. | 6.43 Billion USD | 96.075% |
| Rockwell Medical, Inc. | 8.7 Million USD | -2803.722% |
| Aytu BioPharma, Inc. | 54.58 Million USD | -363.012% |
| SIGA Technologies, Inc. | 122.09 Million USD | -107.008% |
| Tilray Brands, Inc. | 223.35 Million USD | -13.158% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | -503.919% |
| Shineco, Inc. | 882.16 Thousand USD | -28549.872% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 33998.078% |
| Incannex Healthcare Limited | 12 Thousand USD | -2106066.667% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | 86.319% |
| Alimera Sciences, Inc. | 61.17 Million USD | -313.176% |
| Silver Spike Investment Corp. | 8.1 Million USD | -3019.246% |
| Assertio Holdings, Inc. | 125.04 Million USD | -102.113% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | 3710862.003% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | -5930.3% |
| Clever Leaves Holdings Inc. | 6.55 Million USD | -3755.095% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 10586.371% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | -832.035% |
| Hempacco Co., Inc. | -1.21 Million USD | 20887.394% |
| Talphera, Inc. | -4.89 Million USD | 5263.228% |
| Alvotech | -69.42 Million USD | 464.063% |
| Eagle Pharmaceuticals, Inc. | 221.67 Million USD | -14.014% |
| Lantheus Holdings, Inc. | 709.54 Million USD | 64.38% |
| Currenc Group, Inc. | 17.35 Million USD | -1356.186% |
| Kamada Ltd. | 52.59 Million USD | -380.561% |
| Indivior PLC | 907 Million USD | 72.135% |
| Evoke Pharma, Inc. | 4.97 Million USD | -4976.374% |
| Flora Growth Corp. | 17.73 Million USD | -1324.851% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 10586.371% |
| Evolus, Inc. | 140.52 Million USD | -79.853% |
| HUTCHMED (China) Limited | 453.55 Million USD | 44.275% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 26.522% |
| Akanda Corp. | 111.44 Thousand USD | -226676.373% |